Advanced search
Publication Cover
Acta Oncologica Volume 58, 2019 - Issue 6
Journal homepage
3,780
Views
28
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES: CANCER EPIDEMIOLOGY

Cancer incidence and mortality after heart transplantation – A population-based national cohort study

Salla Jäämaa-HolmbergHeart and Lung Center, Helsinki University Hospital, Helsinki, Finland; ;Faculty of Medicine, University of Helsinki, Helsinki, Finland; Correspondence[email protected] [email protected]
ORCID Iconhttp://orcid.org/0000-0001-5287-6096View further author information
ORCID Icon,
Birgitta SalmelaHeart and Lung Center, Helsinki University Hospital, Helsinki, Finland; ;Faculty of Medicine, University of Helsinki, Helsinki, Finland; View further author information
,
Karl LemströmHeart and Lung Center, Helsinki University Hospital, Helsinki, Finland; ;Faculty of Medicine, University of Helsinki, Helsinki, Finland; View further author information
,
Eero PukkalaFinnish Cancer Registry, Institute for Statistical and Epidemiological Cancer Research, Helsinki, Finland; ;Faculty of Social Sciences, University of Tampere, Tampere, FinlandView further author information
&
Jyri LommiHeart and Lung Center, Helsinki University Hospital, Helsinki, Finland; View further author information
Pages 859-863 | Received 20 Sep 2018, Accepted 05 Feb 2019, Published online: 01 Mar 2019

Citations (28)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Zhenyu Huo, Caichen Li, Xin Xu, Fan Ge, Runchen Wang, Yaokai Wen, Haoxin Peng, Xiangrong Wu, Hengrui Liang, Guilin Peng, Run Li, Danxia Huang, Ying Chen, Ran Zhong, Bo Cheng, Shan Xiong, Weiyi Lin, Jianxing He & Wenhua Liang. (2020) Cancer Risks in Solid Organ Transplant Recipients: Results from a Comprehensive Analysis of 72 Cohort Studies. OncoImmunology 9:1.
Read now

Articles from other publishers (27)

Xiaolong Miao, Peng Jiang, Xiaotong Zhang, Xinqiang Li, Zelai Wu, Yuancong Jiang, Han Liu, Weixun Xie, Xinwei Li, Bingfeng Shi, Jinzhen Cai & Weihua Gong. (2024) Lactobacillus rhamnosus HN001 facilitates the efficacy of dual PI3K/mTOR inhibition prolonging cardiac transplant survival and enhancing antitumor effect . Microbiology Spectrum 12:5.
Crossref
Vincenzo CusiFlorin VaidaNicholas WetterstenNicholas RodgersYuko TadaBryn GerdingMarcus Anthony UreyBarry GreenbergEric D. AdlerPaul J. Kim. (2023) Incidence of Acute Rejection Compared With Endomyocardial Biopsy Complications for Heart Transplant Patients in the Contemporary Era. Transplantation 108:5, pages 1220-1227.
Crossref
Marianne Corrêa dos Santos Pimentel, Mariana Magalhães Fernandes, Jéssica de Oliveira Vogel, Clara Herrera Freire, Cláudia Maria Pereira, Bruno Augusto Benevenuto de Andrade, Bruna de Oliveira Rech & Jefferson R. Tenório. (2024) What are the main oral manifestations in heart transplant patients? A scoping review. Special Care in Dentistry.
Crossref
Nadia H Bakir, Ioana B Florea, Jordan Phillipps, Joel D Schilling, Marci S Damiano, Gregory A Ewald, Kunal D Kotkar, Akinobu Itoh, Ralph J DamianoJrJr, Marc R Moon & Muhammad F Masood. (2023) Characterization of de novo malignancy after orthotopic heart transplantation: single-centre outcomes over 20 years . European Journal of Cardio-Thoracic Surgery 64:4.
Crossref
Julie Sagnes, Pascal Battistella, Tom Paunet, Denis Mariano-Goulart & Florentin Kucharczak. (2023) Evaluation of 18-FDG PET diagnostic capabilities for cancer screening in heart transplant patients, a retrospective study. Medicine 102:39, pages e35296.
Crossref
Markus J. BartenMDMD & Hermann ReichenspurnerMDMD. 2023. Textbook of Transplantation and Mechanical Support for End‐Stage Heart and Lung Disease. Textbook of Transplantation and Mechanical Support for End‐Stage Heart and Lung Disease 523 548 .
Christoph Kondziella, Nina Fluschnik, Jessica Weimann, Benedikt Schrage, Peter Moritz Becher, Felix Memenga, Alexander M. Bernhardt, Stefan Blankenberg, Hermann Reichenspurner, Paulus Kirchhof, Renate B. Schnabel & Christina Magnussen. (2023) Sex differences in clinical characteristics and outcomes in patients undergoing heart transplantation. ESC Heart Failure 10:4, pages 2596-2606.
Crossref
Romeo Patini, Massimo Cordaro, Denise Marchesini, Francesco Scilla, Gioele Gioco, Cosimo Rupe, Maria Antonietta D’Agostino & Carlo Lajolo. (2023) Is Systemic Immunosuppression a Risk Factor for Oral Cancer? A Systematic Review and Meta-Analysis. Cancers 15:12, pages 3077.
Crossref
Daphne G. Eckembrecher, Francelia J. Eckembrecher, Isabella Camacho, Hemali Shah, Yogi Dave, Shrey Patel & Keyvan Nouri. (2023) A review of heart transplant immunosuppressants and nonmelanoma skin cancer. Archives of Dermatological Research 315:9, pages 2491-2503.
Crossref
Marta Sagastagoitia-Fornie, Laura Morán-Fernández, Zorba Blázquez-Bermejo, Beatriz Díaz-Molina, Manuel Gómez-Bueno, Luis Almenar-Bonet, Amador López-Granados, Francisco González-Vílchez, Sonia Mirabet-Pérez, Elena García-Romero, Sobrino-Márquez Jose M.Gregorio Rábago Juan-Aracil, Maria Angels Castel-Lavilla, Teresa Blasco-Peiro, Iris Garrido-Bravo, Luis De La Fuente-Galán, Javier Muñiz & María G. Crespo-Leiro. (2023) Incidence and Prognosis of Colorectal Cancer After Heart Transplantation: Data From the Spanish Post-Heart Transplant Tumor Registry. Transplant International 36.
Crossref
William L. Baker, Timothy E. Moore, Eric Baron, Douglas L. Jennings & Abhishek Jaiswal. (2022) Development and Validation of a Model to Predict Malignancy Within the First Year After Adult Heart Transplantation. Progress in Transplantation 33:1, pages 69-77.
Crossref
Lidewij L. Vroonhof, Stefan Roest, Frank R. Datema, Olivier C. Manintveld & Andries P. Nagtegaal. (2023) Evaluation of Routine Ear, Nose, and Throat Screening in Heart Transplant Candidates: A Retrospective Cohort Study. Transplantation Proceedings 55:1, pages 208-213.
Crossref
Emyal Alyaydin, Holger Reinecke, Izabela Tuleta & Juergen R. Sindermann. (2022) Diltiazem as a cyclosporine A-sparing agent in heart transplantation: Benefits beyond dose reduction. Medicine 101:41, pages e31166.
Crossref
Jong-Chan Youn, Darae Kim, In-Cheol Kim, Hye Sun Lee, Jin-Oh Choi, Eun-Seok Jeon, Keith Nishihara, Evan P. Kransdorf, David H. Chang, Michelle M. Kittleson, Jignesh K. Patel, Danny Ramzy, Fardad Esmailian & Jon A. Kobashigawa. (2022) Characteristics, outcomes, and predictors of de novo malignancy after heart transplantation. Frontiers in Cardiovascular Medicine 9.
Crossref
Etienne Charbonneau, Vincent Galand & Erwan Flécher. (2022) Electrical storm due to Epstein-Barr virus-induced lymphoma of a transplanted heart: a case report. European Heart Journal - Case Reports 6:6.
Crossref
Terhi Kristiina Friman, Salla Jäämaa‐Holmberg, Fredrik Åberg, Ilkka Helanterä, Maija Halme, Markku O. Pentikäinen, Arno Nordin, Karl B. Lemström, Timo Jahnukainen, Riikka Räty & Birgitta Salmela. (2022) Cancer risk and mortality after solid organ transplantation: A population‐based 30‐year cohort study in Finland. International Journal of Cancer 150:11, pages 1779-1791.
Crossref
Parvathi Mudigonda, Cecilia Berardi, Vishaka Chetram, Ana Barac & Richard Cheng. (2022) Implications of cancer prior to and after heart transplantation. Heart 108:6, pages 414-421.
Crossref
Karsten M. Heil, Matthias Helmschrott, Fabrice F. Darche, Tom Bruckner, Philipp Ehlermann, Michael M. Kreusser, Andreas O. Doesch, Wiebke Sommer, Gregor Warnecke, Norbert Frey & Rasmus Rivinius. (2021) Risk Factors, Treatment and Prognosis of Patients with Lung Cancer after Heart Transplantation. Life 11:12, pages 1344.
Crossref
L. B. Krougly, N. N. Koloskova, A. V. Nikulin, I. V. Pashkov, V. N. Poptsov & A. O. Shevchenko. (2021) Сlinical features of malignant tumors against the background of immunosuppressive therapy in heart transplant recipients. Russian Journal of Transplantology and Artificial Organs 23:2, pages 167-176.
Crossref
Nandini Nair, Zhiyong Hu, Dongping Du & Enrique Gongora. (2021) Risk Prediction Model for Basal Cell Carcinoma in Cardiac Allograft Recipients. Transplantation Proceedings 53:6, pages 1981-1988.
Crossref
Stefan Roest, Christianne Struijk, Alina A. Constantinescu, Kadir Caliskan, Elsemieke I. Plasmeijer, Eric Boersma, Jasper J. Brugts & Olivier C. Manintveld. (2021) Influence of renal insufficiency pre‐heart transplantation on malignancy risk post‐heart transplantation. ESC Heart Failure 8:3, pages 2172-2182.
Crossref
Antonello SICA, Maria L. DE RIMINI, Caterina SAGNELLI, Beniamino CASALE, Alessandro SPADA, Alfonso REGINELLI, Cristiano AMARELLI, Ciro MAIELLO, Maria P. BELFIORE, Massimiliano CRETA, Massimo CICCOZZI, Evangelista SAGNELLI, Teresa TROIANI & Salvatore CAPPABIANCA. (2021) Post-heart transplantation lymphoproliferative diseases (PTLDs) and the diagnostic role of [18f] FDG-PET/CT. Minerva Medica 112:3.
Crossref
Nandini Nair, Zhiyong Hu, Dongping Du & Enrique Gongora. (2021) Risk prediction model for cutaneous squamous cell carcinoma in adult cardiac allograft recipients. World Journal of Transplantation 11:3, pages 54-69.
Crossref
Thibaut Waeckel, Khelifa Ait Said, Mario Altieri, Annette Belin, Arnaud Doerfler & Xavier Tillou. (2020) Over-diagnosed prostate cancer in solid organ recipients: lessons from the last 3 decades. International Urology and Nephrology 53:2, pages 241-248.
Crossref
Fan Ge, Caichen Li, Xin Xu, Zhenyu Huo, Runchen Wang, Yaokai Wen, Haoxin Peng, Xiangrong Wu, Hengrui Liang, Guilin Peng, Run Li, Danxia Huang, Ying Chen, Shan Xiong, Ran Zhong, Bo Cheng, Jianfu Li, Jianxing He & Wenhua Liang. (2020) Cancer risk in heart or lung transplant recipients: A comprehensive analysis of 21 prospective cohorts. Cancer Medicine 9:24, pages 9595-9610.
Crossref
Felix A. Fröhlich, Fabian Halleck, Lukas Lehner, Eva V. Schrezenmeier, Marcel Naik, Danilo Schmidt, Dmytro Khadzhynov, Katharina Kast, Klemens Budde & Oliver Staeck. (2020) De-novo malignancies after kidney transplantation: A long-term observational study. PLOS ONE 15:11, pages e0242805.
Crossref
Jayant Raikhelkar, Michael Pham, Laura Lourenco, Nikhil Narang, Ben Chung, Ann Nguyen, Gene Kim, Gabriel Sayer & Nir Uriel. (2020) Heart transplantation in patients with localized prostate cancer—Are we denying a life‐saving therapy due to an indolent tumor?. Clinical Transplantation 34:11.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.